DreamCIS Inc Cash Flow Conversion Efficiency

Latest as of September 2025: 0.023x

DreamCIS Inc cash flow conversion efficiency. Based on the latest financial reports, DreamCIS Inc (223250) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩2.17 Billion ≈ $1.47 Million USD) by net assets (₩92.81 Billion ≈ $62.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of DreamCIS Inc (2017–2024)

Cash flow conversion efficiency of DreamCIS Inc from 2017 to 2024. This chart illustrates how DreamCIS Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of DreamCIS Inc for real-time trading data and today's change.

DreamCIS Inc Cash Flow Conversion Ratio Explained

DreamCIS Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

DreamCIS Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of DreamCIS Inc ranked by their cash flow conversion efficiency. Also see DreamCIS Inc stock valuation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Energy Transition Minerals Ltd
AU:ETM
-0.101x
MedFirst Healthcare Services lnc
TWO:4175
0.076x
Electrocore LLC
NASDAQ:ECOR
2.339x
Powertech Industrial Co Ltd
TW:3296
-0.016x
TV Today Network Limited
NSE:TVTODAY
-0.051x
Kron Telekomunikasyon Hizmetleri AS
IS:KRONT
0.156x
Pinar Sut Mamulleri Sanayi AS
IS:PNSUT
0.025x
Alterity Therapeutics Limited
F:PBN
-0.093x

Annual Cash Flow Conversion Efficiency for DreamCIS Inc (2017–2024)

The table below shows the annual cash flow conversion efficiency of DreamCIS Inc from 2017 to 2024. Review free cash flow generation of DreamCIS Inc to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩67.96 Billion
≈ $46.06 Million
₩-85.19 Million
≈ $-57.73K
-0.001x -100.97%
2023-12-31 ₩56.93 Billion
≈ $38.58 Million
₩7.33 Billion
≈ $4.97 Million
0.129x -30.57%
2022-12-31 ₩48.96 Billion
≈ $33.18 Million
₩9.08 Billion
≈ $6.16 Million
0.186x +19.79%
2021-12-31 ₩37.98 Billion
≈ $25.74 Million
₩5.88 Billion
≈ $3.99 Million
0.155x +65.10%
2020-12-31 ₩36.46 Billion
≈ $24.71 Million
₩3.42 Billion
≈ $2.32 Million
0.094x -76.46%
2019-12-31 ₩10.75 Billion
≈ $7.28 Million
₩4.28 Billion
≈ $2.90 Million
0.398x -46.58%
2018-12-31 ₩6.51 Billion
≈ $4.41 Million
₩4.85 Billion
≈ $3.29 Million
0.746x +27.42%
2017-12-31 ₩2.82 Billion
≈ $1.91 Million
₩1.65 Billion
≈ $1.12 Million
0.585x --

About DreamCIS Inc

KQ:223250 Korea Medical Care Facilities
Market Cap
$65.32 Million
₩96.39 Billion KRW
Market Cap Rank
#20612 Global
#1129 in Korea
Share Price
₩4050.00
Change (1 day)
+2.14%
52-Week Range
₩2450.00 - ₩7690.00
All Time High
₩8112.50
About

DreamCIS, Inc. operates as a clinical research organization in South Korea. It offers clinical development services; biostatics, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and regulatory consulting services. The company was founded in 2000 and is headqua… Read more